Gene-Environment Interaction Between Interleukin-4 Promoter and Molds in Childhood Asthma

Annals of Epidemiology

Volumn 22, Issue 4, 2012, Pages 250-256

  Hwang, Bing Fang ^a   Liu, I Ping ^a   Huang, Tzu Pi ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Asthma; Damp housing; Effect modification; Interaction; Interleukin 4 promoter; Molds

Indexed keywords

INTERLEUKIN 4;

ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOULD; ODOR; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AIR POLLUTION, INDOOR; ASTHMA; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FUNGI; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HUMANS; INTERLEUKIN-4; MALE; PROMOTER REGIONS, GENETIC; TAIWAN;

EID: 84859005365     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2012.01.008     Document Type: Article

References (26)

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjuntivitis, and atopic eczema: ISSAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998, 351:1225-1232.
2. NHLBI/WHO workshop report: global strategy for asthma management and prevention, issued January 1995 2002, Global Initiative for Asthma, NIH Publication No. 02-3659, U.S. Government Printing Office, Washington, DC.
3. Holloway J.W., Neghe B., Holgate S.T. The genetic basis of atopic asthma. Clin Exp Allergy 1999, 29:1023-1032.
4. Rosenwasser L.J. Promoter polymorphism in the candidate genes, IL4, IL9, TGF-β1 for atopy and asthma. Int Arch Allergy Immunol 1999, 118:268-270.
5. Cui T., Hu L., Pan S., et al. Association between interleukin-4 and interleukin-4 receptor gene polymorphism and atopic asthma in children. Chin J Pathophysiol 2005, 21:125-128.
6. Lee S.G., Kim B.S., Kim J.H., et al. Gene-gene interaction between interleukin-4 and interleuin-4 receptor alpha in Korean children with asthma. Clin Exp Allergy 2004, 34:1202-1208.
7. Takabayashi A., Ihara K., Sasaki Y., et al. Children atopic asthma: positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp Clin Immunogenet 2000, 17:63-70.
8. Li Y., Guo B., Zhang L., et al. Association between C-589T polymorphisms of interleukin-4 gene promoter and asthma: a meta-analysis. Respir Med 2008, 102:984-992.
9. Wickman M., Melen E., Berglind N., et al. Strategies for preventing wheezing and asthma in small children. Allergy 2003, 58:742-747.
10. Jaakkola J.J., Hwang B.F., Jaakkola N. Home dampness and molds, parental atopy and asthma in children: a six year population-based cohort study. Envrion Health Perspect 2005, 113:357-361.
11. Pekkanen J., Hyvarinen A., Haverinen-Shaughnessy U., Korppi M., Putus T., Nevalainen A. Moisture damage and childhood asthma: a population-based incident case-control study. Eur Respir J 2007, 209:509-515.
12. Hwang B.F., Liu I-Ping, Huang T.P. Molds, parental atopy and pediatric incident asthma. Indoor Air 2011, 21:472-478.
13. Kalilani L., Atashili J. Measuring additive interaction using odds ratios. Epidemiol Perspect Innov 2006, 3:5.
14. Rothman K.J. The estimation of synergy or antagonism. Am J Epidemiol 1976, 103:506-511.
15. Hosmer D.W., Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992, 3:452-456.
16. Nafstad P., Øie L., Mehl R., et al. Residential dampness problems and symptoms and signs of bronchial obstruction in young Norwegian children. Am J Respir Crit Care Med 1998, 157:410-414.
17. Knol M.J., Egger M., Scott P., Greerlings M.I., Vandenbroucke J.P. When one depends on the other: reporting of interaction in case-control and cohort studies. Epidemiology 2009, 20:161-166.
18. Kaufman J.S. Interaction reaction. Epidemiology 2009, 20:159-160.
19. VanderWeele T.J., Robins J.M. The identification of synergism in the sufficient-component-cause framework. Epidemiology 2007, 18:329-339.
20. Norbäck D., Björnsson E., Janson C., Palmgren U., Boman G. Current asthma and biochemical signs of inflammation in relation to building dampness in dwellings. Int J Tuberc Lung Dis 1999, 3:368-376.
21. Husman T. Health effects of indoor-air microorganisms. Scand J Work Environ Health 1996, 22:5-13.
22. Thorn J., Rylander R. Airway's inflammation and glucan in a row house area. Am J Respir Crit Care Med 1989, 157:1798-1803.
23. Johanning E., Landsbergis P., Gareis M., Yang C.S., Olmsted E. Clinical experience and results of a sentinel health investigation related to indoor fungal exposure. Environ Health Perspect 1999, 107(Suppl 3):489-494.
24. Etzel R.A. How environmental exposures influence the development and exacerbation of asthma. Pediatrics 2003, 112:233-239.
25. Mutius E., Martinez F.D., Fritzsch C., Nicolai T., Roell G., Thiemann H.H. Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 1994, 149:358-364.
26. Laitinen T., Räsänen M., Kaprio J., Koskenvuo M., Laitinen L.A. Importance of genetic factors in adolescent asthma: a population-based twin-family study. Am J Respir Crit Care Med 1998, 157:1073-1078.